new version V2017

Idraparinux antithrombotics

idraparinux      

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

atrial fibrillation

AMADEUS, 2008idraparinuxwarfarin standard dose Risk of bias Negative NCT00070655
idraparinux BOREALIS-AF ongoing idraparinuxwarfarin standard dose - NCT00580216

pulmonary embolism

VanGogh PE, 2007idraparinux (without heparin)heparin/VKA Risk of bias Negative NCT00062803

venous thrombosis

VanGogh DVT, 2007idraparinux (without heparin)heparin/VKA Exploratory SuggestingNCT00067093
VanGogh PE, 2007idraparinux (without heparin)heparin/VKA Risk of bias Negative NCT00062803
Van Gogh (subgroup), 2011idraparinuxstandard treatmentpatients with cancer Exploratory Negative